NR1H4 and early-onset autosomal dominant Alzheimer disease: Here, we show that 27-HMA is a novel FXR agonist that may extend the lifespan and healthspan in C. elegans through NHR-regulated functions and may improve the pathogenesis of Alzheimer’s disease (AD) and Parkinson’s disease (PD).